ARTICLE | Clinical News
Anergen regulatory update
August 10, 1998 7:00 AM UTC
ANRG received U.S. Patent No. 5,763,585 covering manufacturing methods for its AnergiX compounds for autoimmune diseases. AnergiX technology combines disease-specific, auto-antigenic peptides with dis...